Raptinal
SIGMA/SML1745 - ≥95% (HPLC)
Synonym: 9H,9′H-9,9′-Bifluorene-9,9′-dicarbaldehyde
CAS Number: 1176-09-6
Empirical Formula (Hill Notation): C28H18O2
Molecular Weight: 386.44
Linear Formula: C28H18O2
Product Type: Chemical
| assay | ≥95% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C28H18O2/c29-17-27(23- |
| InChI key | GLANOOJJBKXTMI-UHFFFAOYSA |
| Quality Level | 100  |
| SMILES string | O=CC(C1=C2C=CC=C1)(C3(C=O |
| solubility | DMSO: 5 mg/mL, clear (warmed) |
| storage temp. | 2-8°C |
| Application: | Raptinal showed complete cytochrome c release within 30 minutes and caspase-3 activation within one hour of exposure (10 μM). Despite its general cytotoxicity in both cancer and non-cancer cell cultures (Cell death induction EC50 = 0.6-3.4 μM in 24 hr), no hematologic toxicity was observed 7 days following single 60 mg/kg i.v. dosing in mice. Studies show that daily i.p. injection (20 mg/kg) is efficacious in suppressing murine B16-F10 melanoma and 4T1 breast cancer expansion in vivo (by ~60% and 50% in 6 days, respectively). |
| Biochem/physiol Actions: | A rapid activator of mitochondrial pathway-mediated intrinsic apoptosis |
| Biochem/physiol Actions: | Raptinal is a cell-permeable bifluorene-dicarbaldehyde compound that acts as a rapid activator of mitochondrial pathway-mediated intrinsic apoptosis. |
| Packaging: | 5 mg in glass bottle |
| Symbol |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P305 + P351 + P338 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |